The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Vaccines, Blood & Biologics
Date: 20 April 2009
To: BLA Committee
From: Lori A. Tull, RAC
Subject: STN 125348/0 Filing Action
I have reviewed the Clinical Study Report (Module 5) section(s) of Isolagen Technologies Incorporated’s BLA (STN Number 125348/0) and find the application acceptable for filing.
(Signature of Committee Member)